Nano Labs Appoints Dr. Kailong Cai as CEO of Subsidiary Nano bit to Lead Global Crypto Reserve Strategy
Nano Labs (NASDAQ: NA) has appointed Dr. Kailong Cai as CEO of its wholly-owned subsidiary, Nano bit HK Limited. Dr. Cai, a finance Ph.D. holder and former Jasper Crypto Fund partner, brings extensive experience in crypto finance and international markets.
Dr. Cai's background includes serving as chief strategy officer at Huobi Group (HTX) and working at Deutsche Bank on Wall Street. He holds both CFA and FRM certifications, with expertise in fintech, blockchain, and asset management.
The appointment aligns with Nano Labs' strategy to become a leading cryptocurrency reserve enterprise in Asia. Under Dr. Cai's leadership, the company plans to accelerate crypto asset reserves, optimize asset-liability structure, and expand globally.
Nano Labs (NASDAQ: NA) ha nominato Dr. Kailong Cai come CEO della sua controllata interamente posseduta, Nano bit HK Limited. Il Dr. Cai, dottore di ricerca in finanza ed ex partner del Jasper Crypto Fund, porta con sé una vasta esperienza nel settore della finanza cripto e nei mercati internazionali.
Il suo background comprende il ruolo di chief strategy officer presso Huobi Group (HTX) e un'esperienza lavorativa presso Deutsche Bank a Wall Street. Possiede le certificazioni CFA e FRM, con competenze in fintech, blockchain e gestione patrimoniale.
Questa nomina è in linea con la strategia di Nano Labs di diventare un'impresa leader nelle riserve di criptovalute in Asia. Sotto la guida del Dr. Cai, la società intende accelerare l'accumulo di riserve di asset cripto, ottimizzare la struttura patrimoniale e passiva e espandersi a livello globale.
Nano Labs (NASDAQ: NA) ha nombrado a Dr. Kailong Cai como CEO de su subsidiaria de propiedad total, Nano bit HK Limited. El Dr. Cai, con doctorado en finanzas y ex socio del Jasper Crypto Fund, aporta una amplia experiencia en finanzas criptográficas y mercados internacionales.
Su trayectoria incluye haber sido director de estrategia en Huobi Group (HTX) y haber trabajado en Deutsche Bank en Wall Street. Posee certificaciones CFA y FRM, con experiencia en fintech, blockchain y gestión de activos.
Este nombramiento está alineado con la estrategia de Nano Labs para convertirse en una empresa líder en reservas de criptomonedas en Asia. Bajo el liderazgo del Dr. Cai, la compañía planea acelerar las reservas de activos cripto, optimizar la estructura de activos y pasivos, y expandirse globalmente.
Nano Labs (NASDAQ: NA)는 전액 출자 자회사인 Nano bit HK Limited의 CEO로 Dr. Kailong Cai를 임명했습니다. 금융 박사 학위를 소지하고 Jasper Crypto Fund의 전 파트너인 Dr. Cai는 암호화폐 금융 및 국제 시장에서 풍부한 경험을 가지고 있습니다.
Dr. Cai는 Huobi Group(HTX)에서 최고 전략 책임자(CSO)로 근무했으며, 월스트리트의 Deutsche Bank에서도 근무한 경력이 있습니다. 그는 CFA 및 FRM 자격증을 보유하고 있으며 핀테크, 블록체인, 자산 관리 분야에 전문성을 갖추고 있습니다.
이번 임명은 Nano Labs가 아시아에서 선도적인 암호화폐 준비금 기업이 되겠다는 전략과 일치합니다. Dr. Cai의 리더십 아래 회사는 암호 자산 준비금을 가속화하고, 자산과 부채 구조를 최적화하며, 글로벌 확장을 추진할 계획입니다.
Nano Labs (NASDAQ : NA) a nommé Dr. Kailong Cai au poste de PDG de sa filiale en propriété exclusive, Nano bit HK Limited. Dr Cai, titulaire d’un doctorat en finance et ancien partenaire du Jasper Crypto Fund, apporte une vaste expérience en finance crypto et sur les marchés internationaux.
Le parcours du Dr Cai inclut un poste de directeur de la stratégie chez Huobi Group (HTX) ainsi qu’une expérience chez Deutsche Bank à Wall Street. Il détient les certifications CFA et FRM, avec une expertise en fintech, blockchain et gestion d’actifs.
Cette nomination s’inscrit dans la stratégie de Nano Labs visant à devenir une entreprise leader des réserves de cryptomonnaies en Asie. Sous la direction du Dr Cai, la société prévoit d’accélérer les réserves d’actifs cryptographiques, d’optimiser la structure actif-passif et de s’étendre à l’international.
Nano Labs (NASDAQ: NA) hat Dr. Kailong Cai zum CEO seiner hundertprozentigen Tochtergesellschaft Nano bit HK Limited ernannt. Dr. Cai, promovierter Finanzwissenschaftler und ehemaliger Partner des Jasper Crypto Fund, bringt umfassende Erfahrungen im Bereich Krypto-Finanzierung und internationalen Märkten mit.
Dr. Cais Hintergrund umfasst die Tätigkeit als Chief Strategy Officer bei der Huobi Group (HTX) sowie eine Anstellung bei der Deutschen Bank an der Wall Street. Er besitzt die CFA- und FRM-Zertifizierungen und verfügt über Fachwissen in Fintech, Blockchain und Vermögensverwaltung.
Die Ernennung steht im Einklang mit der Strategie von Nano Labs, ein führendes Kryptowährungs-Reserveunternehmen in Asien zu werden. Unter der Führung von Dr. Cai plant das Unternehmen, die Krypto-Asset-Reserven zu beschleunigen, die Vermögens- und Schuldstruktur zu optimieren und global zu expandieren.
- Appointment of highly qualified CEO with extensive crypto and finance experience
- Strategic move towards becoming a leading cryptocurrency reserve enterprise
- Enhanced potential for global expansion and market penetration
- Strong leadership addition with both Wall Street and crypto industry expertise
- Transition period may affect short-term operational stability
- Increased exposure to volatile cryptocurrency markets
Insights
Subsidiary CEO appointment signals Nano Labs' strategic pivot toward becoming a crypto reserve company, leveraging Dr. Cai's extensive industry expertise.
This leadership appointment represents a strategic pivot for Nano Labs as it transitions from primarily being a Web 3.0 infrastructure provider toward becoming a cryptocurrency reserve enterprise. Dr. Cai's appointment to lead Nano bit isn't merely a personnel change but signals a fundamental business model evolution.
Dr. Cai brings substantial cryptocurrency expertise with his background at Jasper Crypto Fund and Huobi Group (now HTX), along with traditional finance experience from Deutsche Bank. His dual expertise in both traditional finance (as evidenced by his CFA and FRM credentials) and crypto markets positions him well to execute this strategic shift.
The company appears to be restructuring its focus toward crypto asset reserves rather than just infrastructure. This represents a significant strategic diversification, potentially transforming Nano Labs' revenue model and risk profile. The emphasis on "refining asset-liability structure using capital market instruments" suggests a sophisticated financial approach to managing cryptocurrency holdings.
For a company previously focused on Web 3.0 infrastructure, this evolution toward becoming a publicly listed cryptocurrency reserve could create new opportunities for institutional investors seeking regulated exposure to crypto assets. However, this pivot also introduces new regulatory complexities and market volatilities inherent to cryptocurrency assets.
HONG KONG, July 17, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider in China, today announced the appointment of Dr. Kailong Cai as the chief executive officer (“CEO”) of its wholly-owned subsidiary, Nano bit HK Limited (“Nano bit”). Dr. Cai will be fully responsible for driving Nano bit’s strategic upgrade and overseeing its global operations. This appointment marks a significant step in the Company’s ongoing evolution into a world-leading, publicly listed cryptocurrency reserve enterprise.
Dr. Cai is a renowned expert in crypto finance, with a strong academic background and extensive international experience. He holds a Ph.D. in finance with deep and broad background in both Chinese and U.S. financial markets. From 2020 to 2025, Dr. Cai served as a partner at Jasper Crypto Fund. From 2017 to 2018, Dr. Cai served as the chief strategy officer of Huobi Group (currently known as HTX), a global leader in crypto asset trading, as well as CEO of its U.S. subsidiary, where he led the development and execution of the company’s globalization strategy. Prior to that, he worked for approximately 6 years at Deutsche Bank on Wall Street, specializing in financial product innovation, risk management, and technology-driven business optimization. With over a decade of experience in fintech and asset management, Dr. Cai brings a wealth of knowledge to his new role.
Dr. Cai is a chartered financial analyst (CFA) and financial risk manager (FRM), with deep expertise in fintech, blockchain, and asset management.
Dr. Jianping Kong, Chairman and CEO of Nano Labs, commented on the appointment, “We believe Dr. Cai’s appointment brings visionary leadership and strong strategic execution capabilities to Nano Labs. Under his guidance, Nano Labs will accelerate its strategic reserves of core crypto assets, refine its asset-liability structure using capital market instruments, and further its global expansion. With Dr. Cai on board, we are more confident in achieving our goal of becoming a leading public cryptocurrency reserve company in Asia with global influence, offering investors efficient and transparent access to crypto asset allocation.”
Dr. Cai stated: “It is a great honor to take on this role and contribute to Nano Labs’ ambitious strategic vision. I look forward to working with our talented and forward-thinking team to enhance our crypto asset strategies and capitalize on emerging market trends and technological advancements.”
About Nano Labs Ltd
Nano Labs Ltd is a leading Web 3.0 infrastructure and product solution provider in China. Nano Labs is committed to the development of high throughput computing (“HTC”) chips and high performance computing (“HPC”) chips. Nano Labs has built a comprehensive flow processing unit (“FPU”) architecture which offers solution that integrates the features of both HTC and HPC. In addition, Nano Labs has actively positioned itself in the digital assets space, adopting BNB as its primary reserve asset. It has accumulated nearly US
* According to an industry report prepared by Frost & Sullivan.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company’s plan to appeal the Staff’s determination, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.
For investor inquiries, please contact:
Nano Labs Ltd
ir@nano.cn
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-646-932-7242
Email: investors@ascent-ir.com
FAQ
Who is the new CEO of Nano bit HK Limited and what is his background?
What are Nano Labs' (NASDAQ: NA) strategic goals with this appointment?
What certifications and expertise does Dr. Kailong Cai bring to Nano Labs?
How will Dr. Cai's appointment impact Nano Labs' business strategy?
What was Dr. Kailong Cai's role at Huobi Group (HTX)?
